Garheng Kong

Insider profile

Currently holds positions in Alimera Sciences Inc, Labcorp Holdings Inc. and Strongbridge Biopharma plc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 44% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Alimera Sciences Inc Oct. 1, 2012 -
Independent Director Labcorp Holdings Inc. Dec. 1, 2013 -
Lead Independent Director Strongbridge Biopharma plc Nov. 18, 2019 -
Independent Director Melinta Therapeutics Inc Jan. 1, 2016 - June 11, 2019
Independent Chairman of the Board Ocugen, Inc. July 1, 2012 - Feb. 22, 2019
Independent Chairman of the Board Melinta Therapeutics Inc Nov. 1, 2008 - Jan. 1, 2016
Garheng Kong's trades of Venus Concept Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
161.03
Quantity 29,717 +21.3%
Value US$4,663,823
US Avedro Inc (AVDR)
Transaction date
Purchase
Price
255.23
Quantity 62,474 -2.3%
Value US$1,453,036
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-17 2021-12-15
B Purchase
29,717 +21.3%
161.03
US$4,663,823 		29,717 +21.3% 161.03 US$4,663,823
2019-02-19 2019-02-19
US Avedro Inc (AVDR)
B Purchase
62,474 -2.3%
255.23
US$1,453,036 		62,474 -2.3% 255.23 US$1,453,036